Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial

Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial

Accumulating evidence suggests an association between gut microbiota and the development of obesity, raising the possibility of probiotic administration as a therapeutic approach. Bifidobacterium breve B-3 was found to exhibit an anti-obesity effect on high-fat diet-induced obesity mice. In the pres...

Full description

Bibliographic Details
Main Authors: Jun-ichi Minami, Shizuki Kondo, Naotake Yanagisawa, Toshitaka Odamaki, Jin-zhong Xiao, Fumiaki Abe, Shigeru Nakajima, Yukie Hamamoto, Sanae Saitoh, Taeko Shimoda
Format: Article
Language:English
Published: Cambridge University Press 2015-01-01
Series:Journal of Nutritional Science
Subjects:
Bifidobacterium
Metabolic syndrome
Obesity
Randomised controlled trials
Online Access:https://www.cambridge.org/core/product/identifier/S2048679015000051/type/journal_article

Similar Items

Similar Items